Progress in the application of omalizumab in the treatment of chronic inducible urticaria
Chronic inducible urticaria (CIndU) is a chronic urticaria caused by unique triggers, manifested by wheals and angioedema as common symptoms. Omalizumab is a recombinant humanized anti-IgE antibody, which is currently listed as the third-line treatment for CIndU in international guidelines, and ther...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2024-12-01
|
| Series: | Pifu-xingbing zhenliaoxue zazhi |
| Subjects: | |
| Online Access: | http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.12.010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!